Annual Neuroimmunology and Multiple Sclerosis Clinical and Research Hybrid Program

Friday, December 19, 2025, 12:00 PM - 8:00 PM, Other, Worcester, MA


AMA PRA Category 1 Credits™ (5.00 hours), Contact Hours (MA Board of Nursing) (5.80 hours), Non-Physician Attendance (5.00 hours)

Program Description: UMass symposium on "Considerations of Multiple Sclerosis (MS) in Special Patient Groups" will address the complexities of MS management beyond the general population, focusing on specific demographics with unique clinical needs and life circumstances. 

Our program will include the characteristics of disease in special populations

• MS in the pediatric population: Explore the unique presentation and progression of MS in children and adolescents, including challenges with diagnosis, long-term disease monitoring, and the use of disease-modifying therapies (DMTs).

• Aging with MS: Discuss considerations for older adults, such as managing age-related comorbidities, treatment safety in an aging population, and the increasing risk of progression independent of relapse activity (PIRA).

• MS and pregnancy/family planning: Focus on evidence-based strategies for managing MS in women who are pregnant, breastfeeding, or planning a family. Review the safety of DMTs and considerations for relapse management during and after pregnancy.

• Ethnic and racial considerations: Examine how ethnicity and race can influence MS disease characteristics, treatment response, and outcomes. Highlight genetic factors and health disparities. 

• MS in men: Discuss differences in MS types in men, disease severity and biology of differences of MS between men and women.

Personalized care and therapeutic strategies:

• Individualizing DMT selection: Discuss the process of choosing the most appropriate DMT for a patient based on individual factors like age, disease severity, comorbidities, and lifestyle. This includes balancing efficacy and safety profiles of available treatments.

• Emerging therapies: Review the latest evidence on novel and emerging DMTs and their potential clinical implications for special MS patient-groups.

1. Identify unique disease characteristics and risk factors in special patient populations with MS.
2. Apply evidence-based approaches to personalize treatment decisions, including initial DMT selection and switching strategies.
3. Evaluate emerging therapies and integrate them into management plans for special patient groups.
4. Implement strategies to improve communication, shared decision-making, and medication adherence with diverse patient groups.
5. Develop comprehensive management plans that address specific symptomatic, rehabilitative, and psychosocial needs of individual patients.

Active UMass Department of Neurology Employee, Neurology Residents, Fellows & Students - Free
All Other Health Professionals - $300
Physicians or nurses not affiliated with UMass - $200
UMass Alumnus - $50 

 

UMass Chan Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The UMass Chan designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™.  Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurses: This program meets the requirements for 5.8 contact hours for nurses as specified by the Massachusetts Board of Registration in nursing (244-CMR 5.04). 

Others: Other healthcare professionals will receive a certificate that states this activity was designated for 5 AMA PRA Category 1 Credits™

Cancellation Policy

If you cancel your registration before November 25th, 2025 fee is refundable less a processing charge of $75. After that date, no refund will be given for any reason, including weather and other emergencies, substitutions are always welcome. UMass Chan Office of Continuing Medical Education and the Department of Neurology reserves the right to cancel a program at any time caused by circumstances not under its control.  Persons registered in a canceled program will be notified by email, using the email address provided when registering for the program.  There may also be changes in the program content caused by circumstances beyond the control of the Office of Continuing Medical Education.


Accessibility Statement
 
University of Massachusetts Chan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Beechwood Hotel
 363 Plantation St. Worcester, MA

Phone: 508-444-5850
Website

 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Massachusetts Chan Medical School asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. 

Mitigation of Relevant Financial Relationships

All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, December 19, 2025